Application and Challenges
November 13 – 14, 2013 | Bethesda North Marriott Hotel | Bethesda, MD
Exhibition: November 13 – 14 | Courses: November 12
For a sample of topics to be discussed at the 2013 PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Conference, listen to the podcast by the planning committee co-chairs.
The PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Conference will provide a forum for discussing new molecular virus detection technologies including: massively parallel or deep sequencing, broad range PCR followed by mass spectrometry, and virus microarrays, for the characterization of biological materials used in the production of vaccines and recombinant therapeutic protein products.
• James Brister, Staff Scientist, National Center for Biotechnology Information, National Institutes of Health
• Jean-Pol Cassart, PhD, Senior Scientist, QC Biology, GSK Vaccines
• Kostantin Chumakov, PhD, Associate Director, Research, Office of Vaccines Research and Review, CBER, FDA
• Paul Duncan, PhD, Senior Principle Scientist, Vaccine Bioprocess R&D, Merck
• Tom Slezak, Associate Program Leader, Informatics Global Security Program, Lawrence Livermore National Laboratory
• Glyn Stacey, PhD, Director, Stem Cell Bank, NIBSC, MHRA
• Carolyn Wilson, PhD, Associate Director for Research, CBER, FDA
|Before September 3, 2013||September 3-October 3, 2013||After October 3, 2013|
|Government/Health Authority Member||$ 700||$ 700||$ 700|
|Government/Health Authority Nonmember*||$ 800||$ 800||$ 800|
|Academic Member||$ 700||$ 700||$ 700|
|Academic Nonmember*||$ 800||$ 800||$ 800|
|Student Member||$ 280||$ 280||$ 280|
|Student Nonmember*||$ 310||$ 310||$ 310|
All prices in US dollars.
* For this member type, online registration is not available must be faxed in.
Please note: In order to receive the prevailing registration rate, your registration(s) must be received by PDA by 5:00 p.m. ET on or before the date noted.
Please read PDA's confirmation, substitution, refund and photo release policies for this conference and course.
Register 4 people from the same organization as a group (at the same time) for the conference and receive the 5th registration free. Other discounts cannot be applied.
Please let us know if you have any special dietary requirement we may assist you with. Please contact us at email@example.com.
The 2013 PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Conference will provide your company the premier opportunity to gain access to and connect with key decision makers from the biopharmaceutical science and manufacturing industry. Find new customers, discuss ongoing projects, discover new opportunities, and reconnect with current clients by exhibiting at or sponsoring the industry's leading conference and exhibition in this dynamic field. Extended, dedicated exhibit hall hours will allow ample time for information exchange with attendees and industry subject matter experts from manufacturing, quality control/assurance, formulation, process development, risk assessment, vaccines, and regulatory affairs. Many high-profile, cost-effective sponsorship options are available to help your company increase exposure, build awareness, and stand out from the crowd. Become a sponsor and/or exhibit at the PDA/FDA Advanced Technologies for Virus Detection in the Evaluation of Biologicals Conference and strengthen your brand image, increase your visibility, and gain access to hundreds of leaders in the industry.